Poly(D, L-lactide-co-glycolide)/montmorillonite nanoparticles for improved oral delivery of exemestane. - Wikidata - wikimedia - TriplyDB

Poly(D, L-lactide-co-glycolide)/montmorillonite nanoparticles for improved oral delivery of exemestane.

Poly(D, L-lactide-co-glycolide)/montmorillonite nanoparticles for improved oral delivery of exemestane.

http://www.wikidata.org/entity/Q34630736

about

Enhanced oral bioavailability of acetylpuerarin by poly(lactide-co-glycolide) nanoparticles optimized using uniform design combined with response surface methodology.The therapeutic potential of targeting ABC transporters to combat multi-drug resistance.Shell-crosslinked zein nanocapsules for oral codelivery of exemestane and resveratrol in breast cancer therapy.HPLC Methods for Quantitation of Exemestane-Luteolin and Exemestane-Resveratrol Mixtures in Nanoformulations.The Effects of Physicochemical Properties of Nanomaterials on Their Cellular Uptake In Vitro and In Vivo.Recent Trends in Preparation of Poly(lactide-co-glycolide) Nanoparticles by Mixing Polymeric Organic Solution with Antisolvent

P2860

Q37042544-A4EE42FE-0C0D-4CF1-9D54-565B8978FFD3 Q39196784-AE7D9B3E-5803-467A-ABF2-0C93F3A18333 Q46385678-E39B6E8D-608E-4D4C-9400-AB08185F3B78 Q46627426-C57472C0-B48D-494D-83AE-B093E2DBF758 Q47642966-959F15C7-EE85-4AD1-8DAC-A1C874017C68 Q59113665-7A59F127-AFE5-470D-A097-0958979152B0

P2860

Poly(D, L-lactide-co-glycolide)/montmorillonite nanoparticles for improved oral delivery of exemestane.

http://www.wikidata.org/entity/Q34630736

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Poly(D, L-lactide-co-glycolide ...... d oral delivery of exemestane.

@ast

Poly(D, L-lactide-co-glycolide ...... d oral delivery of exemestane.

@en

Poly(D, L-lactide-co-glycolide ...... d oral delivery of exemestane.

@nl

type

label

Poly(D, L-lactide-co-glycolide ...... d oral delivery of exemestane.

@ast

Poly(D, L-lactide-co-glycolide ...... d oral delivery of exemestane.

@en

Poly(D, L-lactide-co-glycolide ...... d oral delivery of exemestane.

@nl

prefLabel

Poly(D, L-lactide-co-glycolide ...... d oral delivery of exemestane.

@ast

Poly(D, L-lactide-co-glycolide ...... d oral delivery of exemestane.

@en

Poly(D, L-lactide-co-glycolide ...... d oral delivery of exemestane.

@nl

P1433

Q34630736-E37BBCDD-2747-4444-9B68-0A04DB52CC4F

P1476

Q34630736-1969E732-FFD5-4E34-BD05-A59259F222F8

P2093

Q34630736-03ED7F8C-282E-4B71-A00C-70903C475858

Q34630736-22D33941-F80B-4ADC-9C91-3718CA3B328F

Q34630736-5057CAC2-EB0B-492F-BA35-ADA745A9B041

Q34630736-694A99B1-B938-41AE-879B-B0CC7648A108

Q34630736-6F6D5CC8-5870-4361-9581-F5E3F4DB4AC7

Q34630736-9661871F-6D42-4C57-BAB1-C6BC9A7FDBA7

Q34630736-9991D8FC-B43B-4E56-AA9E-50B2EA4A8288

Q34630736-BFE33452-3CAF-4D68-B0F1-587C8207356C

Q34630736-C195B623-A988-4C90-8103-DE8BDFD411B2

P2860

Q34630736-0F1B6870-F58A-4DDE-A629-809428AFA5A2

Q34630736-1B5874C6-9739-460F-9089-C8AF910141AE

Q34630736-1D48F156-8815-4DD3-8F05-E58BB3389CBF

Q34630736-1DE87F5B-230B-42F1-8D02-444708DD4D22

Q34630736-31EE54BB-A319-45EA-85CE-22C6317529C9

Q34630736-353A9878-249A-4A66-8954-64462085933F

Q34630736-4266A9BD-54A1-4231-ADE1-A4306703AADB

Q34630736-4E5460BA-B2B5-48A0-8870-5A7A2ED7CF05

Q34630736-5A124F6E-71D5-4EE3-B61E-C39AEE891D7A

Q34630736-5D3131CF-20CA-4C4D-8819-1119E0633604

P304

Q34630736-2747A2E3-24E0-4089-B3E2-42F65CEA1B28

P31

Q34630736-C28E638F-478E-4F9E-9DD4-E25F7E8BB662

P356

Q34630736-12610120-4C32-49BE-8D2D-148655C5554D

P433

Q34630736-2C990BAA-96B9-4CA5-A7BF-8813A4648B6F

P478

Q34630736-22306916-6EB8-4ABF-A935-20088AA127AF

P577

Q34630736-C4FAA3D1-BA0E-4E7E-AAEE-3EE8C184EBEC

P698

Q34630736-3C6A081D-4A63-40E4-B8E8-C008F3099D1E

P921

Q34630736-D999E1CD-AD99-46B0-9E70-B6E38111FDAF

P356

02652048.2012.746749

P1433

Journal of Microencapsulation

P1476

Poly(D, L-lactide-co-glycolide ...... d oral delivery of exemestane.

@en

P2093

Dawei Chen

http://www.w3.org/2001/XMLSchema#string

Kexin Liu

http://www.w3.org/2001/XMLSchema#string

Lei Li

http://www.w3.org/2001/XMLSchema#string

Lin Mei

http://www.w3.org/2001/XMLSchema#string

Pengyuan Sun

http://www.w3.org/2001/XMLSchema#string

Tangna Hao

http://www.w3.org/2001/XMLSchema#string

Yan Tian

http://www.w3.org/2001/XMLSchema#string

Zeyao Tang

http://www.w3.org/2001/XMLSchema#string

Zhen Li

http://www.w3.org/2001/XMLSchema#string

P2860

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.

A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.

Poly (lactide-co-glycolide) nanoparticles containing coumarin-6 for suppository delivery: in vitro release profile and in vivo tissue distribution.

Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.

Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles.

Oral bioavailability enhancement of exemestane from self-microemulsifying drug delivery system (SMEDDS).

Alternative oral exemestane formulation: improved dissolution and permeation.

Differential scanning calorimetry: applications in drug development.

Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery.

P304

432-440

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/02652048.2012.746749

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23517067

http://www.w3.org/2001/XMLSchema#string

P921